Brief: Race Oncology On-Market Buyback Continued With Additional A$1.2 Mln Invested Via Q1 FY23
27/10/2022 01:59
Oct 27 (Reuters) - Race Oncology Ltd RAC.AX :
* RACE ON-MARKET BUYBACK CONTINUED, WITH ADDITIONAL A$1.2
MILLION
INVESTED THROUGH Q1 FY 2023
Source text for Eikon: ID:nASX3BVqTv
Further company coverage: RAC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Racura Oncology
See all newsAustralia's Racura Oncology jumps most in a month after raising $24 million
Brief: Racura Oncology Says Emerging Companies Specialist Invests In Racura
Brief: Racura Oncology Announces Positive Safety Review Committee Recommendation In Ongoing Cpacs Clinical Trial
Australia's Racura Oncology gains on Purdue University cancer study collab
Brief: Racura Oncology Receives Governance Approval For Harness-1 Phase 1 Trial Of Rc220